Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
S | Common Stock | D | 5026 | $15.00 - $15.00 | $75,398 |
| 2024-11-11 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 10043 | $0.54 - $1.08 | $8,137 |
| 2024-07-24 | Mineralys Therapeutics, Inc. | Catalys Pacific F...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 550000 | $13.05 - $13.05 | $7,177,500 |
| 2024-07-16 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
S | Common Stock | D | 525 | $15.00 - $15.00 | $7,875 |
| 2024-07-16 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 525 | $1.08 - $1.08 | $567 |
| 2024-07-11 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 11366 | $0.54 - $1.08 | $9,565 |
| 2024-07-11 | Mineralys Therapeutics, Inc. | Levy Adam Scott
(CFO and Secretary) |
S | Common Stock | D | 10757 | $13.14 - $13.14 | $141,394 |
| 2024-07-11 | Mineralys Therapeutics, Inc. | Congleton Jon
(Chief Executive Officer) |
S | Common Stock | D | 15746 | $13.34 - $13.34 | $210,075 |
| 2024-06-17 | Mineralys Therapeutics, Inc. | Congleton Jon
(Chief Executive Officer) |
S | Common Stock | D | 49313 | $11.73 - $12.25 | $592,021 |
| 2024-06-12 | Mineralys Therapeutics, Inc. | Congleton Jon
(Chief Executive Officer) |
S | Common Stock | D | 72797 | $12.52 - $12.77 | $924,202 |
| 2024-06-11 | Mineralys Therapeutics, Inc. | Levy Adam Scott
(CFO and Secretary) |
S | Common Stock | D | 96815 | $12.94 - $12.94 | $1,252,718 |
| 2024-06-11 | Mineralys Therapeutics, Inc. | Rodman David Malcom
(Chief Medical Officer) |
M | Common Stock | A | 11366 | $0.54 - $1.08 | $9,565 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |